Skip to main content

Day: April 16, 2025

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 15 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

SRM Entertainment’s Provides Update on Trade Related Market Conditions

Winter Park, FL, April 16, 2025 (GLOBE NEWSWIRE) — SRM Entertainment, Inc. (Nasdaq: SRM) SRM Entertainment maintains a favorable business model for current trade conditions. SRM manufactures products in China and more importantly SRM “passes title” of our products to our largest customers in China. Shipping, tariffs and other duty related expenses are the responsibility of our customers. This business model provides SRM with the ability to mitigate changing trade conditions. In addition, SRM carries inventory of our proprietary products in the United States of approximately $800,000 which is sold through retailers and Amazon. This domestic asset provides the Company with a readily available supply of key products such as lovable plush, back pack clips, drinkware and SRM’s Sip with Me cups including the officially licensed Smurfs...

Continue reading

Global Net Lease Announces Release Date for First Quarter 2025 Results

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”) announced today that it will release its financial results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 after the close of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, May 8, 2025, beginning at 11:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The results will be released before the call which will be conducted by GNL’s management team. A question-and-answer session will follow the prepared remarks. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the Internet and can be accessed...

Continue reading

MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results

MIAMI, April 16, 2025 (GLOBE NEWSWIRE) — MSP Recovery, Inc. (NASDAQ: MSPR) (“MSP,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announced financial results for the fiscal year and fourth quarter ended December 31, 2024. “MSP Recovery has overcome significant industry challenges to become the leader in enforcing Medicare Secondary Payer laws, protecting the Medicare Trust Fund, and paving the road for healthcare reimbursement recoveries,” said MSP Recovery Founder and CEO John H. Ruiz. “We’ve made legal and technological progress, holding primary payers accountable. Through pioneering legal strategy and healthcare innovation, we’ve exposed systemic flaws and secured meaningful settlements from Primary Payers. Our restructuring efforts and proprietary technology...

Continue reading

Awilco Drilling PLC: Minutes from Extraordinary General Meeting 25 October 2024

An Extraordinary General Meeting of Awilco Drilling PLC was held Wednesday 16 April 2025 at 10:00am (UK time), at the Company’s registered office, Suite 1, 7th Floor, 50 Broadway, London, SW1H 0BL, United Kingdom. The resolution set out in the Meeting Notice was duly passed. The signed minutes of meeting are attached hereto. The Meeting Notice is available on our website www.awilcodrilling.com, under ‘Investor Relations/General Meetings’. Aberdeen, 16 April 2025 For further information please contact: Eric Jacobs, Interim CEOPhone: +47 9529 2271 Cathrine Haavind, Investor RelationsPhone: +47 93 42 84 64Email: ch@awilcodrilling.com This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentAWDR EGM Meeting Minutes 16 April 2025 Signed

Continue reading

CURRENC Group Inc. Announces Full Year 2024 Financial Results

SINGAPORE, April 16, 2025 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced its financial results for the full year ended December 31, 2024. Recent Business HighlightsCURRENC launched its strategic business transformation featuring several AI-driven initiatives. These projects position the Company at the forefront of AI innovation, create significant cross-selling opportunities and reinforce the Company’s commitment to delivering cutting-edge financial solutions globally.Launched SEAMLESS AI Call Centre Solutions (“Text AI,” “Voice AI,” and “Avatar AI”) to provide 24/7, multilingual virtual support; Unveiled “AI Staff for Hire,” a suite of customizable AI Agents for tasks...

Continue reading

Ress Life Investments A/S, Decisions of annual general meeting 2025

                                                                        Ress Life Investments A/SNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.com To: Nasdaq CopenhagenDate: 16 April 2025 Corporate Announcement 15/2025 Ress Life Investments A/S announces the events of the annual general meeting held on 16 April 2025. At the annual general meeting of Ress Life Investments A/S held on Wednesday 16 April 2025, the following decisions were taken: •      The Annual Report for the period 1 January – 31 December 2024 was approved – cf item 1 of the agenda. •       Appropriation of the year’s result was approved – cf item 2 of the agenda. •      Gitte Aggerholm was elected to the Board of Directors. Søren Andersen, Jeppe Buskov and Henrik Franck were re-elected to the Board of Directors –...

Continue reading

Discovery Completes Acquisition of Porcupine Complex, Emerges as New Canadian-Based Gold Producer

Growing gold production in one of the world’s most prolific mining camps Large Mineral Resource base with substantial exploration upside A management team with extensive experience working in the Timmins Camp Increased financial strength following closing of $575 million financing packageTORONTO, April 16, 2025 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today reported the completion of the previously announced acquisition (the “Transaction”) of Newmont Corporation’s (“Newmont”) Porcupine Operations (the “Porcupine Complex” or “Porcupine”) based in and near Timmins, Ontario, Canada. All dollar amounts in this press release are in US dollars unless otherwise specified. Tony Makuch, Discovery’s CEO, commented: “With the closing of the Porcupine acquisition, Discovery moves...

Continue reading

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROMEISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize hypercortisolemia in Cushing’s syndrome, a rare endocrine condition that can have significant impact on patients and their families The expanded indication is supported by an extensive clinical development programMilan, Italy and Bridgewater, NJ, April 16, 2025 – Today Recordati announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ISTURISA® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing’s syndrome for whom surgery is not an option or has not been curative. This is an expansion...

Continue reading

Completion of compulsory acquisition of remaining issued and outstanding shares of Avenir LNG Limited

London, April 16, 2025 – Reference is made to the stock exchange announcement of March 5, 2025, stating that Stolt-Nielsen Limited (Oslo Børs: SNI), through its subsidiary Stolt-Nielsen Gas Ltd. had resolved to proceed with a compulsory acquisition of the shares of Avenir LNG Limited (‘Avenir LNG’) not already owned by Stolt-Nielsen Gas Ltd. Stolt-Nielsen Limited is pleased to announce that the compulsory acquisition process has been successfully completed, and Avenir LNG is now fully owned by Stolt-Nielsen Gas Ltd. A request to have Avenir LNG delisted from Euronext N-OTC will be submitted, and it is expected that such delisting will occur shortly. Advisors DNB Markets, a part of DNB Bank ASA, acted as financial advisor to Stolt-Nielsen Limited, and Advokatfirmaet Thommessen AS acted as legal advisor to Stolt-Nielsen Limited, in connection...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.